Astrana Health (STU:3AM) Cyclically Adjusted Revenue per Share: €0.00 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:3AM Astrana Health Inc STU:3AM
76 GF Score
Price €31.00
GF Value €72.92
! 5 Warning Signs
View Full Analysis

What is Astrana Health Cyclically Adjusted Revenue per Share?

Astrana Health STU:3AM +4.73% 76 Cyclically Adjusted Revenue per Share is €0.00 as of Jun. 2026. GuruFocus rates STU:3AM with a GF Score™ of 76/100 and a GF Value™ of €72.92. The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Astrana Health's adjusted revenue per share for the three months ended in Jun. 2026 was €16.958. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €0.00 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Astrana Health's average Cyclically Adjusted Revenue Growth Rate was 30.20% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 24.20% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 24.30% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 27.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Astrana Health was 40.80% per year. The lowest was 20.00% per year. And the median was 24.20% per year.

As of today (2026-08-08), Astrana Health's current stock price is €31.00. Astrana Health's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was €0.00. Astrana Health's Cyclically Adjusted PS Ratio of today is .

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Astrana Health was 10.87. The lowest was 0.67. And the median was 2.21.


Astrana Health  (STU:3AM) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Astrana Health was 10.87. The lowest was 0.67. And the median was 2.21.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Astrana Health Cyclically Adjusted Revenue per Share Related Terms


Astrana Health Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Astrana Health's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Astrana Health Cyclically Adjusted Revenue per Share Chart

Astrana Health Annual Data
Trend Mar16 Mar17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.16 13.54 16.52 21.58 23.80

Astrana Health Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.39 22.75 23.80 26.03 0.00

STU:3AM vs SNDA, SGRY, AVAH: Cyclically Adjusted Revenue per Share Comparison

For the Medical Care Facilities subindustry, Astrana Health's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Astrana Health Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Astrana Health's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Astrana Health's Cyclically Adjusted PS Ratio falls into.


STU:3AM
76GF Score
Astrana Health Inc STU:3AM
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Astrana Health Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Astrana Health's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=16.958/333.9520*333.9520
=16.958

Current CPI (Jun. 2026) = 333.9520.

Astrana Health Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 2.159 241.428 2.986
201612 2.463 241.432 3.407
201703 2.287 243.801 3.133
201706 6.132 244.955 8.360
201709 5.611 246.819 7.592
201712 0.000 246.524 0.000
201803 3.084 249.554 4.127
201806 3.206 251.989 4.249
201809 3.734 252.439 4.940
201812 2.464 251.233 3.275
201903 2.226 254.202 2.924
201906 3.032 256.143 3.953
201909 3.826 256.759 4.976
201912 4.626 256.974 6.012
202003 3.991 258.115 5.164
202006 3.934 257.797 5.096
202009 4.072 260.280 5.225
202012 -3.028 260.474 -3.882
202103 3.395 264.877 4.280
202106 3.181 271.696 3.910
202109 4.172 274.310 5.079
202112 3.787 278.802 4.536
202203 5.197 287.504 6.037
202206 5.544 296.311 6.248
202209 6.937 296.808 7.805
202212 6.104 296.797 6.868
202303 6.708 301.836 7.422
202306 6.871 305.109 7.521
202309 6.953 307.789 7.544
202312 6.869 306.746 7.478
202403 7.799 312.332 8.339
202406 9.416 314.175 10.009
202409 8.944 315.301 9.473
202412 13.231 315.605 14.000
202503 11.747 319.799 12.267
202506 11.476 322.561 11.881
202509 16.465 324.800 16.929
202512 16.384 324.054 16.884
202603 17.018 330.213 17.211
202606 16.958 333.952 16.958

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of €0.00 mean?
Astrana Health (STU:3AM) has a Cyclically Adjusted Revenue per Share of €0.00 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Astrana Health and its competitors.
Is Astrana Health's Cyclically Adjusted Revenue per Share too high?
Astrana Health's current Cyclically Adjusted Revenue per Share is €0.00. Overall, Astrana Health has a GF Score™ of 76/100, reflecting its overall financial health beyond just this single metric.
How does Astrana Health's Cyclically Adjusted Revenue per Share compare to SNDA and SGRY?
Astrana Health's Cyclically Adjusted Revenue per Share of €0.00 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Healthcare Providers & Services company?
A good Cyclically Adjusted Revenue per Share depends on the Healthcare Providers & Services industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Astrana Health and its competitors. Astrana Health's current Cyclically Adjusted Revenue per Share is €0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Astrana Health stock overvalued right now?
Astrana Health (STU:3AM) has a current Cyclically Adjusted Revenue per Share of €0.00. The stock's GF Value™ is €72.92, compared to a current price of €31.00 — trading 57.5% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is €0.00. Astrana Health's overall GF Score™ is 76/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Astrana Health (STU:3AM), the current Cyclically Adjusted Revenue per Share is €0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Astrana Health (STU:3AM) Overvalued in 2026?

Based on GuruFocus' analysis, Astrana Health stock appears to be undervalued. The current stock price of €31.00 is trading 57.5% below its estimated GF Value™ of €72.92.

Key valuation signals for STU:3AM:

  • Cyclically Adjusted Revenue per Share: €0.00
  • GF Value™: €72.92 vs. price of €31.00 (57.5% below fair value)
  • GF Score™: 76/100 with 5 warning signs

No single metric tells the full story. See the STU:3AM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Astrana Health Business Description

Other Exchanges ASTH:USA
Address 1668 South Garfield Avenue, 2nd Floor, Alhambra, CA, USA, 91801
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.
76GF Score

Get the complete analysis for STU:3AM

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€31.00
Price
€72.92
GF Value